Beijing Chunlizhengda Medical Instruments Co Ltd (SHG:688236) — Market Cap & Net Worth
Market Cap & Net Worth: Beijing Chunlizhengda Medical Instruments Co Ltd (688236)
Beijing Chunlizhengda Medical Instruments Co Ltd (SHG:688236) has a market capitalization of $611.59 Million (CN¥4.18 Billion) as of August 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #11211 globally and #3115 in its home market, demonstrating a 2.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Chunlizhengda Medical Instruments Co Ltd's stock price CN¥14.56 by its total outstanding shares 287051149 (287.05 Million). See Beijing Chunlizhengda Medical Instrument (688236) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Beijing Chunlizhengda Medical Instruments Co Ltd Market Cap History: 2021 to 2026
Beijing Chunlizhengda Medical Instruments Co Ltd's market capitalization history from 2021 to 2026. Data shows change from $1.09 Billion to $611.59 Million (-12.64% CAGR).
Beijing Chunlizhengda Medical Instruments Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Chunlizhengda Medical Instruments Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.67x
Beijing Chunlizhengda Medical Instruments Co Ltd's market cap is 0.67 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.30x
Beijing Chunlizhengda Medical Instruments Co Ltd's market cap is 4.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.09 Billion | $1.11 Billion | $322.36 Million | 0.98x | 3.38x |
| 2022 | $954.38 Million | $1.20 Billion | $307.72 Million | 0.79x | 3.10x |
| 2023 | $1.07 Billion | $1.21 Billion | $277.82 Million | 0.88x | 3.84x |
| 2024 | $537.66 Million | $805.86 Million | $124.99 Million | 0.67x | 4.30x |
Competitor Companies of 688236 by Market Capitalization
Companies near Beijing Chunlizhengda Medical Instruments Co Ltd in the global market cap rankings as of August 7, 2026.
Key companies related to Beijing Chunlizhengda Medical Instruments Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #113 globally with a market cap of $187.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #183 globally with a market cap of $129.13 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #240 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #113 | Abbott Laboratories | NYSE:ABT | $187.73 Billion | $107.96 |
| #183 | Stryker Corporation | NYSE:SYK | $129.13 Billion | $337.43 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.92 |
Beijing Chunlizhengda Medical Instruments Co Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Beijing Chunlizhengda Medical Instruments Co Ltd's market cap moved from $1.09 Billion to $ 611.59 Million, with a yearly change of -12.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥611.59 Million | -36.36% |
| 2025 | CN¥961.07 Million | +78.75% |
| 2024 | CN¥537.66 Million | -49.60% |
| 2023 | CN¥1.07 Billion | +11.78% |
| 2022 | CN¥954.38 Million | -12.47% |
| 2021 | CN¥1.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 7th, 2026 the market cap of Beijing Chunlizhengda Medical Instruments Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $611.59 Million USD |
| MoneyControl | $611.59 Million USD |
| MarketWatch | $611.59 Million USD |
| marketcap.company | $611.59 Million USD |
| Reuters | $611.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Chunlizhengda Medical Instruments Co Ltd
Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or… Read more